Public defence: Lene Vernås Halvorsen

MD Lene Vernås Halvorsen at Institute of Clinical Medicine will be defending the thesis “Novel approaches to adherence and personalized treatment in hypertension” for the degree of PhD (Philosophiae Doctor).

Bildet kan inneholde: person, hår, hake, smil, kinn.

Photo: Private

Due to copyright issues, an electronic copy of the thesis must be ordered from the faculty. For the faculty to have time to process the order, the order must be received by the faculty at the latest 2 days before the public defence. Orders received later than 2 days before the defence will not be processed. After the public defence, please address any inquiries regarding the thesis to the candidate.

Trial Lecture – time and place

See Trial Lecture.

Adjudication committee

  • First opponent: Professor Emeritus Michel Burnier, University of Lausanne, Switzerland
  • Second opponent: Associate Professor Jorie Versmissen, Erasmus University Medical Center, the Netherlands
  • Third member and chair of the evaluation committee: Professor Emeritus Trond Geir Jenssen, University of Oslo

Chair of the Defence

Professor Kåre Birkeland, University of Oslo

Principal Supervisor

Aud Høieggen, University of Oslo

Summary

Hypertension can lead to serious illness and premature death. Lifestyle changes and medication are used to lower blood pressure and thereby reduce the risk. In recent years, there has been a focus on the importance of treatment adherence for achieving blood pressure control.

The aim of the thesis was to study important aspects of drug adherence in the treatment of hypertension, i.e. to explore the prevalence of nonadherence as a cause of uncontrolled hypertension in Norway, compare different methods to evaluate adherence, explore factors associated with nonadherence and examine whether information about results of serum drug measurements would improve patients` adherence and blood pressure.

Serum concentrations of 25 antihypertensive drugs were measured in 1) patients treated with a minimum of two antihypertensive agents and 2) patients with resistant hypertension. This objective method of evaluating adherence showed poor compatibility with subjective methods like questionnaires.

Nonadherent patients were younger, had higher blood pressure, were prescribed more antihypertensive tablets and more tablets overall, and they were less frequently prescribed fixed-drug combinations compared to those evaluated as adherent.

1146 patients were included in a national multicenter randomized controlled study to test if information about findings of low or absent serum concentrations of drugs improved blood pressure in patients with uncontrolled hypertension. Forty-six nonadherent patients were randomly assigned to receive information about serum concentrations or not. Adherence and blood pressure improved in both groups, but there was no difference between the groups.

In conclusion, serum drug measurements were useful to detect nonadherence to antihypertensive treatments, but there was no additional improvement in patients` adherence and blood pressure by informing about the results of serum concentrations compared to optimal standard care.

Additional information

Contact the research support staff.

Published Nov. 26, 2025 9:23 AM - Last modified Dec. 9, 2025 11:13 AM